
11 - 50 employees
Founded 2016
🧬 Biotechnology
💊 Pharmaceuticals
🔥 Funding within the last year
💰 $65M Post-IPO Equity - I-Mab Biopharma on 2025-07
Biotechnology • Pharmaceuticals
I-Mab Biopharma is a global biotechnology platform company focused on discovering, developing, and commercializing innovative biologic therapies to accelerate patient access to new medicines. The company advances a clinical-stage pipeline of immuno-oncology and other therapeutic biologics—such as bispecific antibodies and monoclonal antibodies—through internal R&D and partnerships, while engaging in investor relations and regulatory activities to support development and commercialization.
🕒 March 19
Senior Medical Director managing clinical development in oncology and autoimmune areas for Mab Biopharma. Collaborating cross-functionally to drive study design and implementation.
🇺🇸 United States – Remote
🔥 Funding within the last year
💰 $65M Post-IPO Equity - I-Mab Biopharma on 2025-07
⏰ Full Time
🟠 Senior
👨⚕️ Medical Director